Schonfeld Strategic Advisors LLC Ani Pharmaceuticals Inc Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$48.72 - $65.43 $1.36 Million - $1.83 Million	-27,969 Reduced 87.95%	3,831 $211,000
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $915,096 - $1.18 Million	-18,200 Reduced 36.4%	31,800 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $755,122 - $1.09 Million	20,250 Added 68.07%	50,000 $2.69 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $379,710 - $461,589	-10,096 Reduced 25.34%	29,750 $1.18 Million
Q4 2022 Feb 14, 2023	BUY	$31.9 - $41.95 $1.27 Million - $1.67 Million	39,846 New	39,846 $1.6 Million

213

18.6M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.